Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Sutro Biopharma (STRO) Other Gross PP&E Adjustments (2017 - 2025)

Sutro Biopharma (STRO) has disclosed Other Gross PP&E Adjustments for 9 consecutive years, with $22.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 48.1% to $22.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.5 million through Dec 2025, down 48.1% year-over-year, with the annual reading at $22.5 million for FY2025, 48.1% down from the prior year.
  • Other Gross PP&E Adjustments hit $22.5 million in Q4 2025 for Sutro Biopharma, up from -$13.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $43.3 million in Q4 2024 to a low of -$30.1 million in Q3 2021.
  • Historically, Other Gross PP&E Adjustments has averaged -$7.6 million across 5 years, with a median of -$19.7 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 50.23% in 2021 and later soared 36.9% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at $23.0 million in 2021, then surged by 36.9% to $31.5 million in 2022, then increased by 13.18% to $35.7 million in 2023, then rose by 21.43% to $43.3 million in 2024, then crashed by 48.1% to $22.5 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for STRO at $22.5 million in Q4 2025, -$13.3 million in Q3 2025, and -$14.8 million in Q2 2025.